Fall 2016 HIV Update: CCO Independent Conference Coverage of IDWeek and Glasgow 2016
Source: IDWeek and HIV Glasgow 2016*

Module

In this Expert Analysis, Joseph J. Eron, Jr., MD, and Anton L. Pozniak, MD, FRCP, provide an in-depth discussion of the most clinically relevant new data on the management of patients with HIV infection presented at 2 medical conferences in Fall 2016.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply data from studies of antiretroviral agents used to prevent HIV infection
  • Devise management strategies based on the results of recent clinical studies of antiretroviral agents in treatment-naive and treatment-experienced patients
  • Integrate best practices for the management of adverse events associated with HIV, antiretroviral therapy, and comorbidities

Topics covered include:

  • Introduction
  • Prevention of HIV Infection
  • Initial Antiretroviral Therapy
  • Strategies for Switching and Maintenance
  • New Agents and Formulations
  • Neuropsychiatric Adverse Events
  • Other Topics
 

Faculty

  • Joseph J. Eron, Jr.
    MD
    Anton L. Pozniak
    MD, FRCP

Credit Information

  • Release Date:
    January 12, 2017
  • Expiration Date:
    January 11, 2018
  • Physicians:
    maximum of 1.0 AMA PRA Category 1 Credit

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Joseph J. Eron, Jr., MD


Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Joseph J. Eron, Jr., MD, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Gilead Sciences, Merck, Roche Molecular Systems, Tibotec/Janssen, and ViiV; has served on a data and safety monitoring board for TaiMed; and has received funds for research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and ViiV.
 

Anton L. Pozniak, MD, FRCP


Consultant Physician
Director of HIV Services

Department of HIV and Genitourinary Medicine
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom

Anton L. Pozniak, MD, FRCP, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV; fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speaker bureaus) from Gilead Sciences; and funds for research support from Gilead Sciences, Janssen, Merck, and ViiV.
 

Staff

Jennifer M. Blanchette, PhD


Managing Editor

Jennifer M. Blanchette, PhD, has no real or apparent conflicts of interest to report.
 

Megan Cartwright, PhD


Clinical Editor

Megan Cartwright, PhD, has no real or apparent conflicts of interest to report.
 

Jenny Schulz, PhD


Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
 

Edward King, MA


Executive Vice President

Edward King, MA, has no real or apparent conflicts of interest to report.
 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, MBA, Director of Continuing Education, Amanda Sewell, MBA, Manager of Continuing Education, Debbie Price, Registration Database Administrator, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the care of patients at risk of or infected with HIV.


Goal

The goal of this activity is to improve participants’ competence in translating the most clinically significant data from 2 important scientific meetings into practical management strategies for individuals at risk of or infected with HIV infection.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply data from studies of antiretroviral agents used to prevent HIV infection
  • Devise management strategies based on the results of recent clinical studies of antiretroviral agents in treatment-naive and treatment-experienced patients
  • Integrate best practices for the management of adverse events associated with HIV, antiretroviral therapy, and comorbidities
 

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Commercial Support


This program is supported by an educational grant from ViiV Healthcare.

 

Program Medium


This program has been made available online.

 

Site Requirements


  • Internet Explorer 7+, Firefox 3+, Safari 3+, or Chrome
  • JavaScript enabled
  • 1024x768+ screen resolution
  • Adobe Flash Player
 

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 12, 2017, through January 11, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.